The Montreux healthcare fund, which launched last month, has purchased learning disability care homes business The Regard Partnership for £124m with backing from Macquarie Lending.

An Isle of Man domiciled fund, Montreux Healthcare is advised by Montreux Capital Management – a boutique specialising in alternative investments, namely strategies exposed to the residential care sector.

Montreux Capital Management also advises the Luxembourg-domiciled Montreux Care Home Fund, which invests in the residential care sector and targets an income of approximately 8 to 10 per cent annually, net of fees.

Oliver Harris, managing partner at Montreux Capital Management says: “We see huge value in the purchase of The Regard Partnership both in itself and in the synergy it will bring to our existing holdings.”

He adds: “UK healthcare is being increasingly recognised as an attractive investment proposition in the current climate. Few markets have such compelling growth prospects, with the market set to double over the next 20 years. The inflation-proofed income characteristics are proving attractive to investors in search of income and yield, and we are on course to have more than £500m of healthcare assets under management by the end of 2015.”

The Montreux healthcare fund launched on 30 September 2014 with a minimum investment of £10,000.

Find Us

Thameside House
Hurst Road
East Molesey
KT8 9AY

T: + 44 (0) 1932 860 140
E: info@montreuxcm.com

Information on this webpage relates to and is provided by Montreux Capital Management (UK) Limited

The content of this webpage should not be construed as financial advice. Any decision to invest should be made only on the basis of the relevant documentation for each investment. Past performance is not necessarily a guide to future performance. The value of an investment may go down as well as up and investors may not get back the full amount invested. Investments in small unquoted companies carry an above-average level of risk. These investments are highly illiquid and as such, there may not be a readily available market to sell such an investment. Montreux Capital Management (UK) Limited and Sapia Partners LLP (together “the Sponsors,” or “Sponsor”) do not provide specific individual advice on the suitability of investments with regard to a potential investor’s individual circumstances, risk tolerance or investment objectives and investors should seek independent financial advice if they are in any doubt whether a product is suitable for them.

Montreux Capital Management (UK) Limited is an Appointed Representative of Sapia Partners LLP which is authorised and regulated by the Financial Conduct Authority.

ACCEPT